Vanda Pharmaceuticals Inc. sued the Food and Drug Administration on Monday over the agency’s approval of a generic drug application for a sleep medication from one of its competitors.
Nyah Phengsitthy is a journalist who covers legal and business news, with a focus on the pharmaceutical industry. She writes for Bloomberg Law, BNN Bloomberg, and RealClearMarkets, providing in-depth analysis and reporting on FDA regulations, lawsuits, and industry developments. Nyah's expertise lies in examining the intersection of law, healthcare, and business, and she is dedicated to delivering accurate and informative articles to her readers.